The Science 37 Metasite in Action: Accelerating Enrollment for an Infectious Disease Trial

A biopharma company was conducting a phase II randomized controlled trial for an infectious disease. The protocol required the participation of high-risk comorbidity patients ages 65+ or 18+ that tested positive with symptom onset within a short timeframe. Learn how Science 37 delivered:

• A 3-year reduction of the trial timeline
• More than 86% of trial enrollment 
• 94% retention rate

Discover how a virtual site reduced patient burden and how decentralized clinical trial conduct delivered high-quality, compliant data to support both patients and the sponsor.